GlassScriptPhysician profile
Matthew H Ting
NPI 1952334468
$1,660.70
in general payments reported to CMS, 2019-2025
18 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.31 · 2020: $115 · 2021: $380 · 2022: $206 · 2023: $202 · 2024: $313 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $423.20 | 2019-2023 | Liletta |
| Mayne Pharma Commercial LLC | $203.27 | 2025 | Nextstellis, Annovera |
| Lilly USA, LLC | $187.77 | 2023-2025 | Zepbound |
| Novo Nordisk INC | $146.12 | 2023-2025 | Wegovy |
| Axsome Therapeutics, INC. | $144.85 | 2024 | Auvelity |
| Daiichi Sankyo INC. | $121.63 | 2019-2021 | |
| Myovant Sciences INC. | $76.41 | 2021-2022 | |
| Exeltis, USA INC. | $66.89 | 2021-2024 | Slynd |
| Therapeuticsmd, INC. | $59.83 | 2020-2022 | |
| Astellas Pharma US INC | $52.31 | 2025 | Veozah |
| Sumitomo Pharma America, INC. | $44.01 | 2023-2024 | Myfembree |
| Shield Therapeutics INC | $39.09 | 2023 | Accrufer |
| Organon LLC | $24.20 | 2023-2024 | Nexplanon |
| Medicem INC. | $18.21 | 2021 | |
| Boston Scientific Corporation | $16.42 | 2025 | Bulkamid |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $13.33 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.12 | 2020 | |
| Allergan, INC. | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.